SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-22-079982
Filing Date
2022-12-15
Accepted
2022-12-15 11:42:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea170251-424b3_inmedpharma.htm 424B3 203835
2 GRAPHIC image_001.jpg GRAPHIC 5637
  Complete submission text file 0001213900-22-079982.txt   212717
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-268700 | Film No.: 221464176
SIC: 2834 Pharmaceutical Preparations